Talphera (TLPH) Shares Outstanding (2010 - 2026)
Talphera (TLPH) posted quarterly Shares Outstanding (Entity) of $69.8 million for Q1 2026, up 165.8% year-over-year from $26.3 million in Q1 2025, and up 41.55% quarter-over-quarter from $49.3 million in Q4 2025.
Talphera (TLPH) Shares Outstanding (2010 - 2026) Analysis & Trends
Talphera's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $69.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 165.8% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $69.8 million (up 165.8% YoY), while the FY2025 annual figure was $49.3 million, up 90.86% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $69.8 million, up from $49.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $69.8 million in Q1 2026, with the low at $5.2 million in Q1 2023.
- The 5-year median for Shares Outstanding (Entity) is $24.7 million (2024), against an average of $24.1 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) fell 29.41% in 2023, then surged 376.15% in 2024.
- Talphera's Shares Outstanding (Entity) stood at $8.2 million in 2022, then surged by 105.64% to $17.0 million in 2023, then surged by 52.46% to $25.8 million in 2024, then soared by 90.86% to $49.3 million in 2025, then surged by 41.55% to $69.8 million in 2026.
- Business Quant data shows TLPH's Shares Outstanding (Entity) at $69.8 million in Q1 2026, $49.3 million in Q4 2025, and $45.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - | 75.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.82 Mn |
| Mar 31, 2026 | 69.82 Mn |
| Dec 31, 2025 | 42.41 Mn |
| Sep 30, 2025 | 41.45 Mn |
| Jun 30, 2025 | 34.53 Mn |
| Mar 31, 2025 | 26.27 Mn |
| Dec 31, 2024 | 25.85 Mn |
| Sep 30, 2024 | 26.21 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Mar 31, 2024 | 24.72 Mn |
| Dec 31, 2023 | 14.26 Mn |
| Sep 30, 2023 | 16.76 Mn |
| Jun 30, 2023 | 10.92 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 7.39 Mn |
| Sep 30, 2022 | 7.38 Mn |
| Jun 30, 2022 | 7.36 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 5.99 Mn |
| Sep 30, 2021 | 5.96 Mn |